INS and polycystic ovary syndrome: This review explores the pathophysiology of IR in women with PCOS and aims to provide a comprehensive overview of insulin-sensitizing medications in managing the metabolic, endocrine, and reproductive effects of PCOS, with a particular focus on metformin.